









Mercado
/
Acciones
/
nasdaq-cdna
/

CareDx Inc

CDNA

12.804USD

+0.584+4.78%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

710.13MCap. mercado

12.07P/E TTM



CareDx Inc

12.804

+0.584+4.78%

Descripción general Compañía Finanzas

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Información de la empresa

Símbolo de cotizaciónCDNA

Nombre de la empresaCareDx Inc

Fecha de salida a bolsaJul 17, 2014

Director ejecutivoMr. John W. Hanna

Número de empleados644

Tipo de seguridadOrdinary Share

Fin del año fiscalJul 17

Dirección8000 Marina Blvd

CiudadBRISBANE

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal94005

Teléfono14152872300

Sitio Webhttps://www.caredx.com/

Símbolo de cotizaciónCDNA

Fecha de salida a bolsaJul 17, 2014

Director ejecutivoMr. John W. Hanna

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Jessica Meng

Chief Commercial Officer

114.33K

+117.46%

Mr. Abhishek Jain

Chief Financial Officer

110.14K

-8.07%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Jeffrey Adam Novack

General Counsel, Secretary

30.76K

-0.89%

Caroline Corner

Investor Relations

Ms. Jennifer Foley

Chief Product Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Jessica Meng

Chief Commercial Officer

114.33K

+117.46%

Mr. Abhishek Jain

Chief Financial Officer

110.14K

-8.07%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Desglose de ingresos

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

79.86M

0.00%

Rest of the world

4.82M

0.00%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

Estadísticas de accionistas

Actualizado: sáb., 17 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

8.66%

BlackRock Institutional Trust Company, N.A.

7.56%

State Street Global Advisors (US)

4.46%

Baron Capital Management, Inc.

3.93%

Gagnon Securities LLC

3.83%

Other

71.55%

Accionistas

Proporción

The Vanguard Group, Inc.

8.66%

BlackRock Institutional Trust Company, N.A.

7.56%

State Street Global Advisors (US)

4.46%

Baron Capital Management, Inc.

3.93%

Gagnon Securities LLC

3.83%

Other

71.55%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

44.53%

Investment Advisor

41.96%

Hedge Fund

10.10%

Individual Investor

3.41%

Research Firm

2.92%

Pension Fund

0.57%

Bank and Trust

0.32%

Family Office

0.04%

Venture Capital

0.04%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

455

56.93M

102.27%

-3.71M

2025Q1

463

58.20M

104.56%

-2.86M

2024Q4

457

54.99M

99.23%

-4.48M

2024Q3

452

53.78M

101.72%

-11.43M

2024Q2

424

54.82M

104.96%

-13.18M

2024Q1

450

55.58M

107.13%

-14.92M

2023Q4

462

54.27M

100.29%

-16.52M

2023Q3

493

55.98M

103.34%

-21.97M

2023Q2

517

57.57M

107.02%

-21.82M

2023Q1

532

58.67M

109.28%

-16.17M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

4.82M

8.66%

-25.66K

-0.53%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.21M

7.56%

-77.53K

-1.81%

Mar 31, 2025

State Street Global Advisors (US)

2.48M

4.46%

-174.50K

-6.56%

Mar 31, 2025

Baron Capital Management, Inc.

2.19M

3.93%

-17.29K

-0.78%

Mar 31, 2025

Gagnon Securities LLC

1.42M

2.55%

-9.51K

-0.66%

Mar 31, 2025

ARK Investment Management LLC

2.35M

4.22%

-61.72K

-2.56%

Mar 31, 2025

Invesco Advisers, Inc.

1.88M

3.39%

+1.12M

+147.36%

Mar 31, 2025

Ophir Asset Management Pty Ltd

1.62M

2.91%

+1.62M

Mar 31, 2025

Hood River Capital Management LLC

1.58M

2.84%

+1.58M

Mar 31, 2025

Fred Alger Management, LLC

1.43M

2.58%

-179.38K

-11.11%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

ARK Genomic Revolution ETF

3.93%

Invesco Biotechnology & Genome ETF

2.95%

ROBO Global Healthcare Technology & Innovation ETF

1.43%

Invesco Dorsey Wright Healthcare Momentum ETF

1.43%

Global X Genomics & Biotechnology ETF

1.3%

Franklin Genomic Advancements ETF

0.52%

Main Thematic Innovation ETF

0.42%

SPDR S&P Biotech ETF

0.35%

First Trust Small Cap Growth AlphaDEX Fund

0.24%

VictoryShares US Small Mid Cap Value Momentum ETF

0.24%

ARK Genomic Revolution ETF

Proporción3.93%

Invesco Biotechnology & Genome ETF

Proporción2.95%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.43%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporción1.43%

Global X Genomics & Biotechnology ETF

Proporción1.3%

Franklin Genomic Advancements ETF

Proporción0.52%

Main Thematic Innovation ETF

Proporción0.42%

SPDR S&P Biotech ETF

Proporción0.35%

First Trust Small Cap Growth AlphaDEX Fund

Proporción0.24%

VictoryShares US Small Mid Cap Value Momentum ETF

Proporción0.24%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

